Title of article
Challenges of Iranian Clinicians in Dealing with COVID-19: Taking Advantages of The Experiences in Wenzhou
Author/Authors
Li ، Yuping Department of Pulmonary and Critical Care Medicine - First Affiliated Hospital of Wenzhou Medical University , Tahamtani ، Yaser Department of Diabetes, Obesity and Metabolism, Department of Stem Cells and Developmental Biology - Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology - Academic Center for Education, Culture and Research (ACECR) , Totonchi ، Mehdi Department of Stem Cells and Developmental Biology, Department of Genetics - Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine - Academic Center for Education, Culture and Research (ACECR) , Chen ، Chengshui .Department of Pulmonary and Critical Care Medicine - First Affiliated Hospital of Wenzhou Medical University , Hashemian ، Mohammad Reza Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD) - Shahid Beheshti University of Medical Sciences , Amoozegar ، Fatemeh Noncommunicable diseases research center - Fasa University of Medical Sciences , Zhang ، Jin-San Department of Pulmonary and Critical Care Medicine - First Affiliated Hospital of Wenzhou Medical University , Gholampour ، Yousef Department of Internal Medicine - School of Medicine - Fasa University of Medical Sciences , Li ، Xiaokun Department of Pulmonary and Critical Care Medicine - First Affiliated Hospital of Wenzhou Medical University
From page
155
To page
165
Abstract
The novel coronavirus has been spreading since December 2019. It was initially reported in Wuhan, Hubei province of China. Coronavirus disease 2019 (COVID-19) has currently become a pandemic affecting over seven million people worldwide, and the number is still rising. Wenzhou, as the first hit city out of Hubei Province, achieved a remarkable success in effectively containing the disease. A great record was also observed in Wenzhou for the clinical management of COVID-19 patients, leading to one of the lowest death rates in China. Researchers and clinical specialists proposed and formulated combined approaches such as computerized tomography (CT)-scans and molecular assays, as well as using both allopathic and traditional medications to mitigate its effects. Iranian and Chinese specialists and scientists had a communication in clinical, molecular and pharmaceutical aspects of COVID-19. A proper guideline was prepared according to the experiences of Chinese clinicians in managing the full spectrum of COVID-19 patients, from relatively mild to highly complex cases. The purpose of this guideline is to serve a reference in the hospital for specialists so that they may better diagnose cases and provide effective therapies and proposed antiviral and anti-inflammatory drugs for patients.
Keywords
Anti , inflammatory Drug , Antiviral Drug , COVID , 19 , Diagnosis , SARS , CoV , 2
Journal title
Cell Journal (Yakhteh)
Journal title
Cell Journal (Yakhteh)
Record number
2513559
Link To Document